The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
NCT ID: NCT02353689
Last Updated: 2015-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
84 participants
INTERVENTIONAL
2013-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of Choline
NCT03292978
Effect of Galacto-oligosaccharides (GOS) on Faecal Gut Microbiota in Adult Women
NCT05762965
Effect of Bacillus Coagulans in Adults With With Functional Constipation
NCT04997187
The Impact of Compound Probiotic Freeze-dried Powder on Enhancing Gastrointestinal Health
NCT07025798
Effects of Fructan Prebiotics on the Intestinal Microbiota
NCT01277445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low FODMAP group
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
low FODMAP
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
moderate FODMAP group
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
moderate FODMAP
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
high FODMAP group
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
high FODMAP
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low FODMAP
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
moderate FODMAP
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
high FODMAP
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* renal dysfunction (i.e. serum creatinine \> 1.5 mg/dl or blood urea nitrogen \> 25 mg/ml)
* liver dysfunction (i.e. serum aspartate aminotransferase \> 40 U/L or alanine aminotransferase \> 40 U/L)
* uncontrollable diabetes mellitus
* pregnancy, breast-feeding etc.
* severe diarrhea
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dong-A University
OTHER
Oh Yoen Kim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oh Yoen Kim
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oh Yoen Kim, PhD
Role: PRINCIPAL_INVESTIGATOR
Dong-A Univeristy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2-1040709-AB-N-01-201310-BR-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.